Profile
ARDS VRTX REGN VRNA ARGX SGEN
Company Name Aridis Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $8.92K $122.53B $81.42B $72.68B $51.58B $43.15B
Employees 0.04K 6.10K 15.16K 0.21K 1.60K 3.26K
CEO Vu L. Truong Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren David R. Epstein
Ratings
ARDS VRTX REGN VRNA ARGX SGEN
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
ARDS VRTX REGN VRNA ARGX SGEN
Last Close $0.0002 $434.02 $704.31 $106.91 $929.61 $228.74
High 52 - $513.76 $788 $106.91 $929.61 $228.74
Low 52 - $366.54 $482.92 $37.86 $532.27 $228.74
Price vs. 52 Week High 0 % -15.52 % -10.62 % 0 % 0 % 0 %
Price vs. 52 Week Low 0 % 18.41 % 45.84 % 182.38 % 74.65 % 0 %
Total Return
ARDS VRTX REGN VRNA ARGX SGEN
1 Month Return 0 % 4.13 % 21.84 % 0 % 10.19 % 0 %
3 Month Return 100 % 11.32 % 22.74 % 1.06 % 40.57 % 0 %
6 Month Return 100 % -1.06 % 18.51 % 49.92 % 64.35 % 0 %
9 Month Return 100 % -6.08 % 3.57 % 66.4 % 45.48 % 0 %
YTD Return 100 % 7.78 % -1.13 % 130.21 % 51.16 % 0 %
1 Year Return 100 % -3.12 % -5.41 % 180.68 % 61.8 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ARDS VRTX REGN VRNA ARGX SGEN
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -355.21 % 9.76 % 3.92 % -147.93 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Profitability
ARDS VRTX REGN VRNA ARGX SGEN
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 79.1 %
Return on Assets TTM -209.25 % 14.78 % 11.11 % -11.01 % 15.06 % -16.61 %
Return on Equity TTM 164.69 % 21.81 % 14.83 % -30.05 % 18.96 % -20.8 %
Return on Capital Employed TTM 135.09 % 19.59 % 10.3 % -8.31 % 5.04 % -21.46 %
Net Income Per EBT TTM 101.24 % 82.61 % 86.12 % 111.64 % 237.3 % 101.33 %
EBT Per Ebit TTM 101.26 % 111.4 % 146.19 % 130.36 % 147.38 % 98.26 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -475.15 % 202.64 % 184 % -29.66 % 932.29 % -1043.73 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.91
Payables Turnover TTM - 0.4 2.1 2.37 0.9 1.97
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 0.96
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 665.41 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -1.55 14.55 48.39 -0.85 5.67 -2.46
Free Cash Flow Per Share TTM -1.56 13.06 39.66 -0.85 5.58 -2.88
Cash Per Share TTM 25.97 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.28 % 89.76 % 81.96 % 100.75 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -475.15 % 202.64 % 184 % -29.66 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM - 36.72 19.95 -995.27 129.37 -81.26
Price To Operating Cash Flows Ratio TTM - 32.86 16.2 -126.33 146.05 -93.1
Price Cash Flow Ratio TTM - 32.86 16.2 -126.33 146.05 -93.1
Income Statement (TTM)
ARDS VRTX REGN VRNA ARGX SGEN
Revenue $0B $12.07B $14.34B $0.03B $2.19B $1.96B
Gross Profit $0B $10.27B $12.24B $0.03B $1.96B $1.55B
Gross Profit Ratio 0% 85.03% 85.35% 93.89% 89.62% 79.1%
EBITDA $-0.03B $4.97B $5.82B $-0.12B $0.11B $-0.62B
Net Income $-0.03B $3.95B $4.5B $-0.14B $0.83B $-0.61B
EPS Diluted -1.64 15.32 41.48 -1.73 12.78 -3.3
Balance Sheet (MRQ)
ARDS VRTX REGN VRNA ARGX SGEN
Long Term Debt $0B $3.8B $2.71B $0.12B $0.03B $0.04B
Total Liabilities $0.04B $7.48B $9.3B $0.27B $0.7B $0.87B
Total Equity $-0.02B $18.67B $31.26B $0.2B $5.5B $2.8B
Total Investments $0B $7.33B $15.75B $0.02B $1.93B $1.42B
Total Debt $0.01B $3.88B $2.71B $0.12B $0.04B $0.04B
Total Assets $0.01B $26.14B $40.56B $0.47B $6.2B $3.67B
Cash Flow Statement (TTM)
ARDS VRTX REGN VRNA ARGX SGEN
Net Income $-0.03B $3.95B $4.5B $-0.17B $0.83B $-0.61B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $-0.23B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.03B $3.63B $4.98B $-0.12B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.44B $-0.9B $-0B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.82
AARD Aardvark Therapeutics, Inc. Common Stock 12.1
ABCL AbCellera Biologics Inc. 3.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.01
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.51
ABPWW 0.0131
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 3.98
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.99
ACAD ACADIA Pharmaceuticals Inc. 22.03
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.2
ACIU AC Immune SA 2.99
ETFs With Exposure to ARDS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 336.65
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.23
Unlock